IJID regions最新文献

筛选
英文 中文
Introducing article numbering to IJID Regions 将文章编号引入 IJID 区域
IJID regions Pub Date : 2024-06-01 DOI: 10.1016/S2772-7076(24)00064-X
{"title":"Introducing article numbering to IJID Regions","authors":"","doi":"10.1016/S2772-7076(24)00064-X","DOIUrl":"https://doi.org/10.1016/S2772-7076(24)00064-X","url":null,"abstract":"","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277270762400064X/pdfft?md5=5984037cc83ffc3248ff95f4c30efd73&pid=1-s2.0-S277270762400064X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141429005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avian ‘Bird’ Flu – undue media panic or genuine concern for pandemic potential requiring global preparedness action? 禽'鸟'流感--媒体的过度恐慌还是对需要采取全球备灾行动的大流行可能性的真正担忧?
IJID regions Pub Date : 2024-06-01 DOI: 10.1016/j.ijregi.2024.100367
Eskild Petersen , Ziad A Memish , David S Hui , Alessandra Scagliarini , Lone Simonsen , Edgar Simulundu , Jennifer Bloodgood , Lucille Blumberg , Shui-Shan Lee , Alimuddin Zumla
{"title":"Avian ‘Bird’ Flu – undue media panic or genuine concern for pandemic potential requiring global preparedness action?","authors":"Eskild Petersen , Ziad A Memish , David S Hui , Alessandra Scagliarini , Lone Simonsen , Edgar Simulundu , Jennifer Bloodgood , Lucille Blumberg , Shui-Shan Lee , Alimuddin Zumla","doi":"10.1016/j.ijregi.2024.100367","DOIUrl":"https://doi.org/10.1016/j.ijregi.2024.100367","url":null,"abstract":"","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000389/pdfft?md5=ca485471e1203101375fdf729ec59b96&pid=1-s2.0-S2772707624000389-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141286289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the performance of commercial serological tests for SARS-CoV-2 diagnosis 评估用于诊断 SARS-CoV-2 的商业血清学测试的性能
IJID regions Pub Date : 2024-06-01 DOI: 10.1016/j.ijregi.2024.100383
Leonardo Maia Leony , Larissa Carvalho Medrado Vasconcelos , Ricardo Sampaio Hein da Silva , Aquiles Assunção Camelier , Antônio Carlos Bandeira , Deivide Luis Souza Costa , Isadora Cristina de Siqueira , Fred Luciano Neves Santos
{"title":"Assessing the performance of commercial serological tests for SARS-CoV-2 diagnosis","authors":"Leonardo Maia Leony ,&nbsp;Larissa Carvalho Medrado Vasconcelos ,&nbsp;Ricardo Sampaio Hein da Silva ,&nbsp;Aquiles Assunção Camelier ,&nbsp;Antônio Carlos Bandeira ,&nbsp;Deivide Luis Souza Costa ,&nbsp;Isadora Cristina de Siqueira ,&nbsp;Fred Luciano Neves Santos","doi":"10.1016/j.ijregi.2024.100383","DOIUrl":"10.1016/j.ijregi.2024.100383","url":null,"abstract":"<div><h3>Objectives</h3><p>The emergence of SARS-CoV-2 has triggered a global pandemic with profound implications for public health. Rapid changes in the pandemic landscape and limitations in <em>in vitro</em> diagnostics led to the introduction of numerous diagnostic devices with variable performance. In this study, we evaluated three commercial serological assays in Brazil for detecting anti-SARS-CoV-2 antibodies.</p></div><div><h3>Methods</h3><p>We collected 90 serum samples from SARS-CoV-2-negative blood donors and 352 from SARS-CoV-2-positive, unvaccinated patients, categorized by symptom onset. Subsequently, we assessed the diagnostic performance of three commercial enzyme immunoassays: GOLD ELISA (enzyme-linked immunosorbent assay) COVID-19 Ig (immunoglobulin) G + IgM, Anti-SARS-CoV-2 NCP IgM ELISA, and Anti-SARS-CoV-2 NCP IgG ELISA.</p></div><div><h3>Results</h3><p>Our findings revealed that the GOLD ELISA COVID-19 IgG + IgM exhibited the highest sensitivity (57.7%) and diagnostic odds ratio, surpassing the manufacturer's reported sensitivity in most analyzed time frames while maintaining exceptional specificity (98.9%). Conversely, the Anti-SARS-CoV-2 NCP IgG ELISA demonstrated lower sensitivity but aligned with independent evaluations, boasting a specificity of 100%. However, the Anti-SARS-CoV-2 NCP IgM ELISA exhibited lower sensitivity than claimed, particularly in samples collected shortly after positive reverse transcription polymerase chain reaction results. Performance improved 15-21 days after symptom onset and beyond 22 days, but in the first week, both Anti-SARS-CoV-2 NCP IgM ELISA and Anti-SARS-CoV-2 NCP IgG ELISA struggled to differentiate positive and negative samples.</p></div><div><h3>Conclusions</h3><p>Our study emphasizes the need for standardized validation protocols to address discrepancies between manufacturer-claimed and actual performance. These insights provide essential information for health care practitioners and policymakers regarding the diagnostic capabilities of these assays in various clinical scenarios.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000547/pdfft?md5=72f324bf4f26887807919956171f78ae&pid=1-s2.0-S2772707624000547-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141229840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic usage patterns in COVID-19 patients in five tertiary hospitals from Bangladesh: A countrywide picture 孟加拉国五家三级医院 COVID-19 患者的抗生素使用模式:全国情况
IJID regions Pub Date : 2024-05-31 DOI: 10.1016/j.ijregi.2024.100381
Tabiha Binte Hannan , Shrebash Paul , Md. Mohiuddin Khan , Binayak Bhattacharjee , Md. Zainal Abedin , Pritish Tarafder , T.M. Al-Amin , Muhammad Abdullah Al Amin , Md. Sayedur Rahman , Fazle Rabbi Chowdhury
{"title":"Antibiotic usage patterns in COVID-19 patients in five tertiary hospitals from Bangladesh: A countrywide picture","authors":"Tabiha Binte Hannan ,&nbsp;Shrebash Paul ,&nbsp;Md. Mohiuddin Khan ,&nbsp;Binayak Bhattacharjee ,&nbsp;Md. Zainal Abedin ,&nbsp;Pritish Tarafder ,&nbsp;T.M. Al-Amin ,&nbsp;Muhammad Abdullah Al Amin ,&nbsp;Md. Sayedur Rahman ,&nbsp;Fazle Rabbi Chowdhury","doi":"10.1016/j.ijregi.2024.100381","DOIUrl":"https://doi.org/10.1016/j.ijregi.2024.100381","url":null,"abstract":"<div><h3>Objectives</h3><p>Irrational and injudicious use of antibiotics in COVID-19 patients could be detrimental in a tropical country with a weak antibiotic stewardship policy such as Bangladesh. This study aimed to focus on the antibiotic usage patterns in COVID-19 patients in Bangladesh.</p></div><div><h3>Methods</h3><p>This prospective observational study was performed from July 2020 to June 2021 in five tertiary hospitals in Bangladesh. Data on demographic profile, disease severity, and antibiotic usage were collected directly from the patients’ hospital documents.</p></div><div><h3>Results</h3><p>A total of 3486 (94.4%) patients were treated with at least one antibiotic; 3261 (93.6%) patients received a single antibiotic, and 225 (6.5%) received multiple antibiotics. The most used antibiotics were ceftriaxone (37.3%), co-amoxiclav (26.3%), azithromycin (10.6%), and meropenem (10.3%). According to the World Health Organization AWaRe categorization, most (2260; 69.6%) of the antibiotics prescribed in this study belonged to the “Watch” group. Culture and sensitivity reports were available in 111 cases from one center. Only 18.9% of the patients were found to be co-infected with multi-drug-resistant bacteria (52.4% yield from sputum, 28.6% from urine, and 14.3% from blood).</p></div><div><h3>Conclusions</h3><p>Strict antibiotic prescribing policy and antibiotic stewardship should be implemented immediately to limit the future threat of antimicrobial resistance in countries such as Bangladesh.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000523/pdfft?md5=abb7ce1b058f0b55c27fcb8c6bb0e4cc&pid=1-s2.0-S2772707624000523-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141329109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated local lockdowns for SARS-CoV-2 epidemic control—assessment of effect by controlled interrupted time series analysis 为控制 SARS-CoV-2 疫情而自动实施地方封锁--通过受控中断时间序列分析评估效果
IJID regions Pub Date : 2024-05-25 DOI: 10.1016/j.ijregi.2024.100380
Laura Espenhain , Steen Ethelberg , Laust Hvas Mortensen , Lasse Engbo Christiansen
{"title":"Automated local lockdowns for SARS-CoV-2 epidemic control—assessment of effect by controlled interrupted time series analysis","authors":"Laura Espenhain ,&nbsp;Steen Ethelberg ,&nbsp;Laust Hvas Mortensen ,&nbsp;Lasse Engbo Christiansen","doi":"10.1016/j.ijregi.2024.100380","DOIUrl":"https://doi.org/10.1016/j.ijregi.2024.100380","url":null,"abstract":"<div><h3>Objectives</h3><p>During the COVID-19 pandemic, broad non-pharmaceutical interventions such as national lockdowns were effective but had significant drawbacks, prompting targeted approaches, such as Denmark's localized lockdowns, based on specific epidemiological criteria. This study evaluates the effect of Denmark's automated local lockdown strategy on epidemic control to inform future response.</p></div><div><h3>Methods</h3><p>This was a register-based controlled interrupted time series analysis, examining SARS-CoV-2 infection rates in Danish parishes from March to September 2021. The matching of control parishes was based on location, time, and pre-lockdown infection trends, with the lockdown's start defined as the day after a parish exceeded the lockdown criteria. Follow-up included 3-week pre-lockdown and 2-week post-lockdown.</p></div><div><h3>Results</h3><p>A total of 30 parishes were mandated to lockdown, approximately 3.5% of the population of Denmark. A total of 94 control parishes were used as 109 controls. The decrease in the incidence during the 2-week follow-up period after the initiation of the lockdown was 13% points higher in case parishes: in case parishes, the incidence was reduced by 78% compared with 65% in control parishes.</p></div><div><h3>Conclusions</h3><p>Our findings demonstrate that local lockdowns did have a positive effect in mitigating the spread of the SARS-CoV-2 virus, making them valuable in the fight against the COVID-19 pandemic and an important alternative to national lockdowns.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000511/pdfft?md5=1f0278ad45bb259cd3453a608a04662b&pid=1-s2.0-S2772707624000511-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BA.5 sub-lineages associated with higher severity of COVID-19 infection: A cross-sectional study in Indonesia BA.5 与 COVID-19 感染严重程度相关的亚系:印度尼西亚的一项横断面研究
IJID regions Pub Date : 2024-05-09 DOI: 10.1016/j.ijregi.2024.100379
Yovita Hartantri , Basti Andriyoko , Josephine Debora , Febi Ramdhani Rachman , Evan Susandi , Ferdy Ferdian , Ahmad Rizal Ganiem , Bachti Alisjahbana , Arto Yuwono Soeroto , Dewi Kartika Turbawaty
{"title":"BA.5 sub-lineages associated with higher severity of COVID-19 infection: A cross-sectional study in Indonesia","authors":"Yovita Hartantri ,&nbsp;Basti Andriyoko ,&nbsp;Josephine Debora ,&nbsp;Febi Ramdhani Rachman ,&nbsp;Evan Susandi ,&nbsp;Ferdy Ferdian ,&nbsp;Ahmad Rizal Ganiem ,&nbsp;Bachti Alisjahbana ,&nbsp;Arto Yuwono Soeroto ,&nbsp;Dewi Kartika Turbawaty","doi":"10.1016/j.ijregi.2024.100379","DOIUrl":"10.1016/j.ijregi.2024.100379","url":null,"abstract":"<div><h3>Objectives</h3><p>We aimed to compare the clinical severity and outcome among laboratory-confirmed Omicron variant cases admitted between January and December 2022.</p></div><div><h3>Methods</h3><p>This is a cross-sectional study conducted in Hasan Sadikin General Hospital between January and December 2022. We enrolled patients aged ≥18 years with laboratory-confirmed Omicron infection. Data were collected from clinical records and a whole genome sequencing database. We compared the risk of severe symptoms and mortality using a logistic regression analysis adjusted for sex, age, comorbidities, and vaccination status.</p></div><div><h3>Results</h3><p>We enrolled 255 patients and the main sub-lineages were BA.1 (16.1%), BA.2 (11.4%), BA.5 (35.7%), XBB (22.7%), and BQ.1 (14.1%). Compared with BA.1/BA.2, BA.5 sub-lineages were associated with severe symptoms (adjusted odds ratio of 2.9, 95% confidence interval 1.1-8.2, <em>P</em> &lt;0.05). The highest risk of severe symptoms and mortality was linked with a high number of comorbidities (adjusted odds ratio of 7.8, 95% confidence interval 1.7-22.4, <em>P</em> &lt;0.05). Booster vaccination was protective of severity and mortality.</p></div><div><h3>Conclusions</h3><p>Disease severity was associated with BA.5 sub-lineages and multiple comorbidities. Good management is particularly important for people with comorbidities. Furthermore, booster vaccination is also required to reduce severity and mortality.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277270762400050X/pdfft?md5=5044a1da1d0c3b2fcc36d9b202933128&pid=1-s2.0-S277270762400050X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141044988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare case of human Ancylostoma ceylanicum infection in Bangladesh 孟加拉国罕见的宿主疽感染病例
IJID regions Pub Date : 2024-05-08 DOI: 10.1016/j.ijregi.2024.100376
Tilak Chandra Nath , Proloy Chakraborty Tusher , Tarek Siddiki , Jannatul Nyema , Tiluttom Bhattacharjee , Nilotpal Dey , Mandira Mukutmoni , Kazi Mehetazul Islam , Jamal Uddin Bhuiyan
{"title":"Rare case of human Ancylostoma ceylanicum infection in Bangladesh","authors":"Tilak Chandra Nath ,&nbsp;Proloy Chakraborty Tusher ,&nbsp;Tarek Siddiki ,&nbsp;Jannatul Nyema ,&nbsp;Tiluttom Bhattacharjee ,&nbsp;Nilotpal Dey ,&nbsp;Mandira Mukutmoni ,&nbsp;Kazi Mehetazul Islam ,&nbsp;Jamal Uddin Bhuiyan","doi":"10.1016/j.ijregi.2024.100376","DOIUrl":"10.1016/j.ijregi.2024.100376","url":null,"abstract":"<div><p>The zoonotic hookworm species <em>Ancylostoma ceylanicum</em> has drawn more attention recently because of its potential impact on public health. Although <em>A. duodenale</em> and <em>Necator americanus</em> are more common, <em>A. ceylanicum</em> is still known to play a major role in human infections, particularly in regions where close human-animal interactions are prevalent. While there has been a notable increase in documenting the presence of <em>A. ceylanicum</em> in the Asia-Pacific area, bottlenecks remains in understanding its epidemiology in Bangladesh. This report highlights the first documented case of <em>Ancylostoma ceylanicum</em> infection isolated and identified in a 15-year-old girl experiencing frequent diarrhea and weakness, residing in an urban tea garden area in Sylhet, Bangladesh. Microscopic examination of stool samples revealed the presence of hookworm eggs and subsequent culture led to the observation of larvae. Molecular investigation by amplifying Internal Transcribed Spacer (ITS1+) regions of the ribosomal deoxyribonucleic acid (rDNA) confirmed the infection as <em>A. ceylanicum</em>. The identification of <em>Ancylostoma ceylanicum</em> in a human host in Bangladesh carries significant implications for global health. The careful measurement of eggs and larvae, coupled with molecular analysis, serves as an appropriate diagnostic strategy for confirming the infections. This finding emphasizes the emergence of <em>A. ceylanicum</em> as a zoonotic infection in endemic regions and calls for increased awareness among healthcare professionals and the general public.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277270762400047X/pdfft?md5=d83bd7862fcde06c1130bf5b4eb70df5&pid=1-s2.0-S277270762400047X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141058111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnant women with chronic hepatitis B virus infection at the assessment of tenofovir disoproxil fumarate prescription: Baseline characteristics of a prospective cohort study in Vietnam 评估富马酸替诺福韦酯处方时的慢性乙型肝炎病毒感染孕妇:越南前瞻性队列研究的基线特征
IJID regions Pub Date : 2024-05-07 DOI: 10.1016/j.ijregi.2024.100375
Tran Dieu Hien Pham , Manh Hung Le , Quang Duy Pham , Khanh Lam Phung , Minh Ngoc Nguyen , Thi Bich Ngoc Ha , Bach Khoa Dao , Thanh Phuong Le , Thanh Dung Nguyen , Quoc Cuong Hoang
{"title":"Pregnant women with chronic hepatitis B virus infection at the assessment of tenofovir disoproxil fumarate prescription: Baseline characteristics of a prospective cohort study in Vietnam","authors":"Tran Dieu Hien Pham ,&nbsp;Manh Hung Le ,&nbsp;Quang Duy Pham ,&nbsp;Khanh Lam Phung ,&nbsp;Minh Ngoc Nguyen ,&nbsp;Thi Bich Ngoc Ha ,&nbsp;Bach Khoa Dao ,&nbsp;Thanh Phuong Le ,&nbsp;Thanh Dung Nguyen ,&nbsp;Quoc Cuong Hoang","doi":"10.1016/j.ijregi.2024.100375","DOIUrl":"10.1016/j.ijregi.2024.100375","url":null,"abstract":"<div><h3>Objectives</h3><p>We aimed to determine epidemiological characteristics and serologic markers among chronically hepatitis B virus (HBV)-infected pregnant women during the assessment of tenofovir disoproxil fumarate (TDF) prescription in Vietnam.</p></div><div><h3>Methods</h3><p>We consecutively recruited 375 pregnant women with chronic HBV (cHBV) infection at week 25±2 of pregnancy, at which time they were assessed for TDF use as pre-prophylaxis and/or pre-treatment at the Hospital for Tropical Diseases in southern Vietnam during December 2019-April 2021. Demographic characteristics, serological biomarkers, and prenatal liver ultrasounds were obtained through interviews and reviews of medical records.</p></div><div><h3>Results</h3><p>The median age of pregnant women was 29 years (interquartile range: 26-32). More than half of pregnant women (208/375; 55.5%) started TDF for prevention of mother-to-child transmission of HBV and/or treatment of chronic hepatitis B (CHB). Among the pregnant women initiating TDF, 96.1% (198/206) tested positive for hepatitis B e antigen, and 21.6% (45/208) had quantitative hepatitis B surface antigen (qHBsAg) ≤10<sup>4</sup> IU/mL. A relatively strong correlation between qHBsAg and HBV deoxyribonucleic acid (DNA) (<em>r</em> = 0.81; 95% CI: 0.76-0.85) was observed in pregnant women starting TDF.</p></div><div><h3>Conclusions</h3><p>Our results demonstrate the high need for TDF prescription for prevention and/or treatment purposes in pregnant women with cHBV infection. Pregnant women with qHBsAg levels ≤10<sup>4</sup> IU/mL may prioritize HBV DNA testing over qHBsAg to decide on TDF prescription.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000468/pdfft?md5=c65e6f0a6bf3e71f1ea9666fea4373c3&pid=1-s2.0-S2772707624000468-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141030059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment 评估 HHV-8 病毒载量的两种商业诊断方法
IJID regions Pub Date : 2024-05-06 DOI: 10.1016/j.ijregi.2024.100374
Honorine Fenaux , Lina Mouna , Corinne Vieux-Combe , Isabelle Thouard , Philippe Colliot , Anne-Marie Roque-Afonso
{"title":"Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment","authors":"Honorine Fenaux ,&nbsp;Lina Mouna ,&nbsp;Corinne Vieux-Combe ,&nbsp;Isabelle Thouard ,&nbsp;Philippe Colliot ,&nbsp;Anne-Marie Roque-Afonso","doi":"10.1016/j.ijregi.2024.100374","DOIUrl":"10.1016/j.ijregi.2024.100374","url":null,"abstract":"<div><h3>Objectives</h3><p>Human herpesvirus-8 (HHV-8) can cause Kaposi's sarcoma or B lymphoproliferative disorders such as multicentric Castleman disease. Patient follow-up is based on assessing the HHV-8 viral load, which is usually achieved using real-time polymerase chain reaction (PCR). The HHV-8 Premix r-gene kit (BioMérieux) was used by some laboratories in the past, but BioMérieux ceased the production and distribution of this kit in 2021-2022. Other kits need to be tested so that they can be used for diagnostic purposes. Here we evaluated two commercial kits: HHV8 ELITe MGB Kit (ELITech) and Quanty HHV-8 (Clonit) and compared them with the HHV-8 Premix r-gene kit.</p></div><div><h3>Methods</h3><p>We used whole blood samples that had previously been tested with the HHV-8 Premix r-gene kit for diagnostic purposes. Overall, 46 samples (37 HHV-8-positive and 9 HHV-8-negative) were tested with the ELITe MGB Kit and 37 (29 HHV-8-positive and 8 HHV-8-negative) with the Quanty HHV-8 kit. The different methods were compared using Bland-Altman and Passing-Bablok tests with Analyse-it software.</p></div><div><h3>Results</h3><p>Qualitative results were concordant except for one HHV-8 low-positive sample that was found to be negative by the ELITe MGB Kit. The quantitative results were also concordant; both kits showed mean differences of 0.58 log<sub>10</sub> copies/ml and 0.73 log<sub>10</sub> copies/ml, respectively, compared to the Premix r-gene kit.</p></div><div><h3>Conclusions</h3><p>Both the methods tested produced acceptable results and could be used for diagnostic purposes. It should be remembered that there is no international standard for HHV-8 quantification and that patients should always be followed using the same method.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000456/pdfft?md5=6201631651d13e973061c4c7101e9dc3&pid=1-s2.0-S2772707624000456-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region 太平洋地区新喀里多尼亚首次出现 SARS-CoV-2 流行后的 SARS-CoV-2 和季节性冠状病毒血清流行研究
IJID regions Pub Date : 2024-05-01 DOI: 10.1016/j.ijregi.2024.100373
Karl Huet , Michael White , Anne-Fleur Griffon , Emma Bloch , Elodie Magnat , Gaelle Baudemont , Catherine Inizan , Pascale Domingue Mena , Myrielle Dupont-Rouzeyrol
{"title":"A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region","authors":"Karl Huet ,&nbsp;Michael White ,&nbsp;Anne-Fleur Griffon ,&nbsp;Emma Bloch ,&nbsp;Elodie Magnat ,&nbsp;Gaelle Baudemont ,&nbsp;Catherine Inizan ,&nbsp;Pascale Domingue Mena ,&nbsp;Myrielle Dupont-Rouzeyrol","doi":"10.1016/j.ijregi.2024.100373","DOIUrl":"https://doi.org/10.1016/j.ijregi.2024.100373","url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to determine the seroprevalence of immunoglobulin G antibodies targeting SARS-CoV-2 and other human coronaviruses after the first circulation of SARS-CoV-2 in New Caledonia, Pacific region.</p></div><div><h3>Methods</h3><p>Blood samples were collected to detect the presence of SARS-CoV-2 immunoglobulin G antibodies. The sampling took place between July 2021 and July 2022 but was interrupted after the first circulation of SARS-CoV-2 (September 2021-March 2022) in New Caledonia. Data on ethnicity, age, gender, main residence, and anteriority of COVID-19 and vaccination were collected and analyzed.</p></div><div><h3>Results</h3><p>A total of 747 participants, representative of New Caledonia's adult population, were included in the study. We found that 81% of the population had antibody responses to SARS-CoV-2 at the end of July 2022. The vaccination rate was 75%, whereas infections had affected 40% of the population. Individuals aged &gt;45 years were significantly more vaccinated than those aged 18-44 years (80%, 95% confidence interval 74-84%). Oceanians were the most infected (50%, 95% confidence interval 42-57%).</p></div><div><h3>Conclusion</h3><p>In New Caledonia, we show a high immunity rate (81%) after the first waves of SARS-CoV-2 circulation and the vaccination campaign. The analyses showed spatial heterogeneities in the infection rate across the territory and revealed that Oceanians were the most infected. Our study also highlighted high exposure of New Caledonia's population to other human coronaviruses.</p></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772707624000444/pdfft?md5=67f907a0e9198ebb6484388f606e1e73&pid=1-s2.0-S2772707624000444-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140951675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信